Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...

(Reuters) -Kenvue cut its annual sales forecast on Thursday, as the consumer health company undergoes a strategic review aiming to boost brand performance amid a cautious spending environment. The ...

The chief stewards of the Texas Republican Party agenda have been unrelenting in their efforts to ban taxpayer-funded lobbying. Texas Senate Republicans, a Republican Party resolution, and both ...

Burn your hand on a hot stove and, almost instantly, immune cells within the wound begin producing inflammatory compounds to help clear out dead tissue and fight off infection. In most cases, the ...

Kenvue cuts 2025 sales forecast Says strategic review continues to advance Analysts see Kenvue as potential acquisition target Aug 7 (Reuters) - Kenvue (KVUE.N), opens new tab cut its annual sales ...